Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study

Highlights • We found significant survival differences by country in Europe for haematological malignancies (HM) in 2000’s. • Population-based survival for HM was poorest in Eastern Europe and highest in Central and Northern Europe. • Morphology sub-type, age at diagnosis and, to a lesser extent, ge...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of cancer (1990) Vol. 51; no. 15; pp. 2254 - 2268
Main Authors:	De Angelis, Roberta, Minicozzi, Pamela, Sant, Milena, Dal Maso, Luigino, Brewster, David H, Osca-Gelis, Gemma, Visser, Otto, Maynadié, Marc, Marcos-Gragera, Rafael, Troussard, Xavier, Agius, Dominic, Roazzi, Paolo, Meneghini, Elisabetta, Monnereau, Alain
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01-10-2015
Subjects:	Cancer registry Europe Hematology, Oncology and Palliative Medicine Hodgkin lymphoma Leukaemia Lymphoma Multiple myeloma Non-Hodgkin lymphoma Relative survival Non-Hodgkin lymphoma Cancer registry Relative survival Europe Multiple myeloma Lymphoma Leukaemia Hodgkin lymphoma
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Highlights • We found significant survival differences by country in Europe for haematological malignancies (HM) in 2000’s. • Population-based survival for HM was poorest in Eastern Europe and highest in Central and Northern Europe. • Morphology sub-type, age at diagnosis and, to a lesser extent, gender were relevant prognostic factors. • Survival gaps were largest for chronic myeloid leukaemia and lowest for Hodgkin’s Lymphoma. • Survival gaps were higher for sub-types that benefited more from therapeutic advances.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0959-8049 1879-0852
DOI:	10.1016/j.ejca.2015.08.003